Brincidofovir

Overview

Brincidofovir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL203321).

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Brincidofovir expires 9 Oct 2034 and exclusivity 3 Jun 2028. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethyl-(3-hexadecoxypropoxy)phosphinic acid

Canonical SMILES

CCCCCCCCCCCCCCCCOCCCOP(=O)(CO[C@@H](CN1C=CC(=NC1=O)N)CO)O

InChIKey

WXJFKKQWPMNTIM-VWLOTQADSA-N